5,13,17-Trihydroxy-12-(hydroxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.03,8.014,18]octadeca-1(11),3(8),4,6,12,14(18)-hexaene-4-carbaldehyde

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5,13,17-Trihydroxy-12-(hydroxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.03,8.014,18]octadeca-1(11),3(8),4,6,12,14(18)-hexaene-4-carbaldehyde
• 英文别名: 5,13,17-trihydroxy-12-(hydroxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.03,8.014,18]octadeca-1(11),3(8),4,6,12,14(18)-hexaene-4-carbaldehyde
• 化学式: C₁₈H₁₆O₈
• 分子量: 360.3
• InChiKey: JMKCIUJYMYSXLD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  26
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  126
• 氢给体数：
  4
• 氢受体数：
  8

文献信息

• Small Molecular Inhibitors of RAD51 Recombinase and Methods Thereof
  申请人：Mazin Alexander V.

  公开号：US20140080849A1

  公开（公告）日：2014-03-20

  The invention includes compositions comprising a selective small-molecule inhibitor of RAD51 recombinase and a pharmaceutically acceptable carrier. The invention further includes methods of treating or preventing cancer in a subject, comprising the step of administering to the subject the compositions contemplated within the invention.
• US9216177B2
  申请人：——

  公开号：US9216177B2

  公开（公告）日：2015-12-22